SCHEMBL24026135

SCHEMBL24026135

Oc1ccc2c3c4sc5ccccc5c4ccc3n(-c3ccccn3)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.36
▸ KMT2A Q03164 2/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ MAT2A P31153 2/20 0.33
▸ MAPT P10636 3/20 0.32
▸ POLB P06746 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ MCL1 Q07820 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ NLRP3 Q96P20 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ HCRTR1 O43613 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246469 0.88 KMT2A (0.35) KMT2AMAT2AMAPTPOLBKDM4E
SCHEMBL24026137 0.86 MAT2A (0.35) ESR2KMT2AMAT2AMAPTPOLB
SCHEMBL24026098 0.85 ESR2 (0.39) ESR2KMT2AALOX5MAT2AMAPT
SCHEMBL24026265 0.84 KDM4E (0.41) KMT2AMAT2AMAPTKDM4EMEN1
SCHEMBL24026092 0.81 MAT2A (0.36) ESR2KMT2AMAT2AMAPTPOLB
SCHEMBL24026175 0.81 KMT2A (0.37) ESR2KMT2AMAT2AMAPTPOLB
SCHEMBL15335546 0.80 KRAS (0.34) KMT2AMAT2AMAPTPOLBKDM4E
SCHEMBL24026132 0.78 KDM4E (0.41) KMT2AMAT2AMAPTPOLBKDM4E
SCHEMBL29992464 0.77 MAT2A (0.40) KMT2AMAT2AMAPTPOLBKDM4E
SCHEMBL15063380 0.77 MAT2A (0.40) KMT2AMAT2AMAPTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES UNIV ARIZONA STATE (US) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359224-A1 TETRADENTATE PLATINUM AND PALLADIUM COMPLEXES BASED ON BISCARBAZOLE AND ANALOGUES PDCD2L, PDCD1, PDCD4 ESR2 3778/4885KMT2A 2798/4885ALOX5 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback